Outcome of 3q26.2/MECOM rearrangements in chronic myeloid leukemia.
Akiyama H, Kantarjian H, Jabbour E, Issa G, Haddad FG, Short NJ, Hu S, Ishizawa J, Andreeff M, Sasaki K.
Akiyama H, et al. Among authors: hu s.
Int J Hematol. 2024 May 15. doi: 10.1007/s12185-024-03787-z. Online ahead of print.
Int J Hematol. 2024.
PMID: 38748089